Neuphoria Therapeutics Inc. (NEUP) quarterly cash flow statement — complete operating, investing & financing history
Neuphoria Therapeutics Inc. (NEUP) cash flow statement — 28-year operating, investing & financing cash flows
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|
| Cash from Operations | -1.13M | 1.19M | -3.34M | -6.44M | -3.79M | 73.57M | 11.45M | -3.36M | -4.43M | -3.01M | -5.07M | -3.95M | -4.43M |
| Operating CF Margin % | - | 101.14% | - | - | - | -702.48% | 76.36% | -506.72% | -44.1% | - | - | - | - |
| Operating CF Growth % | 70.26% | -98.39% | -129.13% | -91.65% | 14.4% | 2543.43% | 325.72% | 14.88% | -0.07% | - | - | - | - |
| Net Income | -1.43M | -4.9M | -505.06K | 1.86M | -9.91M | -378.15M | 11.26M | -1.94M | -804.79K | -2.69M | -4.28M | -4.55M | -5.47M |
| Depreciation & Amortization | 165.68K | 165.68K | 165.69K | 165.79K | 165.79K | 161.31K | 165.43K | 166.12K | 165.71K | 165.69K | 254.43K | 165.69K | 165.91K |
| Stock-Based Compensation | 74.72K | 146.62K | 0 | 93.7K | 111.28K | 163.71M | 19.68K | 19.08K | 26.74K | 107.72K | 26.76K | 556.98K | 132.74K |
| Deferred Taxes | -34.79K | -139.03M | -38.93K | -69.59K | 0 | -468.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 90.98K | 144.72M | -638.08K | -3.37M | 4.44M | 754.92M | 648.69K | -1.27M | -2.62M | -2.85M | 625.66K | 98.96K | 228.04K |
| Working Capital Changes | 0 | 98.09K | -2.32M | -5.12M | 1.4M | 1.35M | -642.52K | -328.16K | -1.2M | 2.26M | -1.7M | -212.34K | 516.08K |
| Change in Receivables | 113.21K | 819.33K | -558.5K | -1.66M | 10.19K | 12.59K | 10.97K | 80.4K | 10.92K | -21.18K | 14.85K | 326.99K | -16.25K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 339.11K | -256.18K | 86.1K | -1.28M | 216.36K | 0 | -785.33K | 204.67K | -917.67K | 1.66M | -1.33M | -874K | 880.61K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | 0% | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 109.95K | 0 | 14.66M | 3.25M | 701.49K | 1.16M | -111.56K | -227.34K | 7.12M | 2.69M | 5.63M | 612.54K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 109.95K | 698.95K | 22.01M | 3.25M | -794.29K | 823.6K | 227.34K | 409 | 2.12M | 2.21M | 288.78K | 6.26M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -698.95K | -7.35M | 0 | 1.5M | 338.9K | -338.9K | -227.75K | 5M | 479.58K | 5.34M | -5.65M |
| Net Change in Cash | -1.12M | 424.88K | -2.81M | 8.52M | -560.49K | 14.27B | 12.7M | -3.75M | -4.52M | 4.18M | -2.67M | 2.02M | -3.97M |
| Free Cash Flow | -1.13M | 1.21M | -3.34M | -6.44M | -3.79M | 73.57M | 11.45M | -3.36M | -4.43M | -3.01M | -5.07M | -3.95M | -4.43M |
| FCF Margin % | - | 103.38% | - | - | - | -702.48% | 76.36% | -506.72% | -44.1% | - | - | - | - |
| FCF Growth % | 70.26% | -98.35% | -129.13% | -91.65% | 14.4% | 2543.43% | 325.72% | 14.88% | -0.07% | - | - | - | - |
| FCF per Share | -0.21 | 0.22 | -0.62 | -1.42 | -1.69 | 45.33 | 0.05 | -0.01 | -0.02 | -0.03 | -0.04 | -0.03 | -0.04 |
| FCF Conversion (FCF/Net Income) | 0.79x | -0.24x | 6.61x | -3.45x | 0.25x | -4.95x | 1.02x | 1.73x | 5.51x | 1.12x | -0.44x | 0.59x | 0.52x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |